One-year outcomes of ziv-aflibercept for macular edema in central retinal vein occlusion.

about

One-year outcomes of ziv-aflibercept for macular edema in central retinal vein occlusion.

Item

http://www.wikidata.org/entity/Q47162242

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

One-year outcomes of ziv-aflibercept for macular edema in central retinal vein occlusion.

@en

One-year outcomes of ziv-aflibercept for macular edema in central retinal vein occlusion.

@nl

type

Item

label

One-year outcomes of ziv-aflibercept for macular edema in central retinal vein occlusion.

@en

One-year outcomes of ziv-aflibercept for macular edema in central retinal vein occlusion.

@nl

prefLabel

One-year outcomes of ziv-aflibercept for macular edema in central retinal vein occlusion.

@en

One-year outcomes of ziv-aflibercept for macular edema in central retinal vein occlusion.

@nl

P1476

One-year outcomes of ziv-aflibercept for macular edema in central retinal vein occlusion.

@en

P2093

Ahmad Mansour

http://www.w3.org/2001/XMLSchema#string

Errol W Chan

http://www.w3.org/2001/XMLSchema#string

Jay Chhablani

http://www.w3.org/2001/XMLSchema#string

Mohab Eldeeb

http://www.w3.org/2001/XMLSchema#string

P2860

The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia

CLINICAL AND ELECTROPHYSIOLOGICAL EVALUATION AFTER INTRAVITREAL ZIV-AFLIBERCEPT FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION.

Soluble vascular endothelial growth factor receptor-2 and inflammatory factors in macular edema with branch retinal vein occlusion.

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD

Ziv-aflibercept in macular disease.

INTRAVITREAL INJECTIONS OF ZIV-AFLIBERCEPT FOR DIABETIC MACULAR EDEMA: A Pilot Study.

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion.

Natural history of central retinal vein occlusion: an evidence-based systematic review.

Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature.

Ziv-aflibercept: a novel angiogenesis inhibitor for the treatment of metastatic colorectal cancer.

P304

58-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AJOC.2017.10.011

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chintan J Dedhia

P577

2017-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29260119

http://www.w3.org/2001/XMLSchema#string

P932

5731707

http://www.w3.org/2001/XMLSchema#string